Stay updated on UC-961 in Relapsed CLL Clinical Trial

Sign up to get notified when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UC-961 in Relapsed CLL Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:19:25.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about the investigational drug cirmtuzumab and its clinical trial, while adding a new revision number and a mention of Chronic Lymphocytic Leukemia.
    Difference
    36%
    Check dated 2025-04-16T09:53:59.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T04:41:52.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:10:23.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-25T13:17:24.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-18T05:10:36.000Z thumbnail image

Stay in the know with updates to UC-961 in Relapsed CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.